Conditional Sailing Order Technical Instructions and Operations Manual
| Published date | 10 May 2021 |
| Record Number | 2021-09895 |
| Section | Notices |
| Court | Centers For Disease Control And Prevention,Health And Human Services Department |
24865
Federal Register / Vol. 86, No. 88 / Monday, May 10, 2021 / Notices
of New Hampshire’s request to revise its
part 142—National Primary Drinking
Water Regulations Implementation
program to allow electronic reporting
will become effective 30 days after this
notice is published, pursuant to
CROMERR section 3.1000(f)(4).
Dated: May 3, 2021.
Jennifer Campbell,
Director, Office of Information Management.
[FR Doc. 2021–09793 Filed 5–7–21; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Notice of Termination of Receiverships
The Federal Deposit Insurance
Corporation (FDIC or Receiver), as
Receiver for each of the following
insured depository institutions, was
charged with the duty of winding up the
affairs of the former institutions and
liquidating all related assets. The
Receiver has fulfilled its obligations and
made all dividend distributions
required by law.
N
OTICE OF
T
ERMINATION OF
R
ECEIVERSHIPS
Fund Receivership name City State
Termination
date
10311 ..... Cooper Star Bank ............................................................................. Scottsdale .................................... AZ 05/01/2021
10313 ..... Tifton Banking Company ................................................................... Tifton ........................................... GA 05/01/2021
10353 ..... Bartow County Bank ......................................................................... Cartersville .................................. GA 05/01/2021
10371 ..... McIntosh State Bank ......................................................................... Jackson ....................................... GA 05/01/2021
10377 ..... High Trust Bank ................................................................................ Stockbridge ................................. GA 05/01/2021
10419 ..... The First State Bank ......................................................................... Stockbridge ................................. GA 05/01/2021
10426 ..... Central Bank of Georgia ................................................................... Ellaville ........................................ GA 05/01/2021
The Receiver has further irrevocably
authorized and appointed FDIC-
Corporate as its attorney-in-fact to
execute and file any and all documents
that may be required to be executed by
the Receiver which FDIC-Corporate, in
its sole discretion, deems necessary,
including but not limited to releases,
discharges, satisfactions, endorsements,
assignments, and deeds. Effective on the
termination dates listed above, the
Receiverships have been terminated, the
Receiver has been discharged, and the
Receiverships have ceased to exist as
legal entities.
(Authority: 12 U.S.C. 1819)
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on May 5, 2021.
Debra A. Decker,
Deputy Executive Secretary.
[FR Doc. 2021–09868 Filed 5–7–21; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Conditional Sailing Order Technical
Instructions and Operations Manual
AGENCY
: Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION
: Notice.
SUMMARY
: The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the
availability of additional technical
instructions and documents released
under its Framework for Conditional
Sailing Order (CSO). These documents
apply to cruise ship operators with
cruise ships operating in U.S. waters
and cruise ship operators who are
operating cruise ships outside of U.S.
waters, but intend for their cruise ships
to return to operating in U.S. waters
while CDC’s Conditional Sailing Order
remains in effect.
DATES
: These documents were available
April 2, 2021 and May 5, 2021.
FOR FURTHER INFORMATION CONTACT
:
Jennifer Buigut, Division of Global
Migration and Quarantine, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H16–4, Atlanta,
GA 30329. Phone: 404–498–1600.
Email: dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION
: On
October 30, 2020 CDC issued an Agency
Order establishing a framework for a
phased approach to resuming cruise
ship passenger operations in U.S. waters
(85 FR 70153). The phased approach
includes: (1) Establishment of laboratory
testing of crew onboard cruise ships in
U.S. waters; (2) simulated voyages
designed to test a cruise ship operators’
ability to mitigate COVID–19 onboard
cruise ships; (3) a certification process;
and (4) a return to passenger voyages in
a manner that mitigates the risk of
COVID–19 introduction, transmission,
or spread among passengers and crew
onboard ships and ashore to
communities.
In the initial crew testing phase, the
Order additionally contained
requirements for: (1) Shoreside COVID–
19 laboratory screening testing of all
crew currently onboard cruise ships; (2)
onboard diagnostic testing capabilities
for symptomatic travelers (crew and
future passengers); (3) shoreside
COVID–19 laboratory screening testing
of all newly embarking crew; and (4)
continued compliance with complete,
accurate, and acknowledged, No Sail
Order Response Plans.
On April 2, 2021 CDC released Phase
2A Technical Instructions. Phase 2A
Technical Instructions assists cruise
ship operators in documenting the
approval of U.S. port and local health
authorities as a condition of receiving or
retaining controlled free pratique to
conduct a simulated voyage or to obtain
a COVID–19 Conditional Sailing
Certificate to commence restricted
passenger voyages. This includes
documenting the approval of U.S. port
and local health authorities in
developing medical care, housing, and
port components (including a
vaccination component).
On May 5, 2021 CDC released two
documents under Phase 2B and Phase 3
of the Conditional Sailing Framework:
Technical Instructions for Simulated
Voyages by Cruise Ship Operators under
CDC’s Framework for Conditional
Sailing Order and COVID–19 Operations
Manual for Simulated and Restricted
Voyages under the Framework for
Conditional Sailing Order.
The Technical Instructions for
Simulated Voyages provides technical
instructions for Phase 2B of CDC’s CSO
VerDate Sep<11>2014 19:05 May 07, 2021 Jkt 253001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\10MYN1.SGM 10MYN1
khammond on DSKJM1Z7X2PROD with NOTICES
24866
Federal Register / Vol. 86, No. 88 / Monday, May 10, 2021 / Notices
for cruise ship operators to test the
efficacy of their health and safety
protocols in U.S. waters. In lieu of
conducting a simulated voyage, a cruise
ship operator’s responsible officials, at
their discretion, may sign and submit to
CDC an attestation under 18 U.S.C. 1001
that 98 percent of crew are fully
vaccinated and submit to CDC a clear
and specific vaccination plan and
timeline to limit cruise ship sailings to
95 percent of passengers who have been
verified by the cruise ship operator as
fully vaccinated prior to sailing.
CDC’s oversight and inspection of
cruise ships during simulated and
restricted passenger voyages will be
based on the Operations Manual. The
findings and/or observations of these
inspections will be shared with the
cruise ship operator. Cruise ship
operators are expected to align their
health and safety protocols with any
CDC findings and observations. Such
findings and observations must also be
incorporated into the cruise ship
operator’s simulated voyage after-action
report or as a condition of applying for
and retaining permission to conduct
restricted passenger voyages. Based on
these inspections, CDC may also issue
additional recommendations to the
cruise ship operator that the operator
should consider for adoption into their
health and safety protocols as best
practices.
The Technical Instructions document
for Cruise Ship Operator’s Agreement
with Port and Local Health Authorities
under CDC’s Framework for Conditional
Sailing Order is found at https://
www.cdc.gov/quarantine/cruise/
instructions-local-agreements.html.
The Technical Instructions document
for Simulated Voyages by Cruise Ship
Operators under CDC’s Framework for
Conditional Sailing Order is found at
https://www.cdc.gov/quarantine/cruise/
ti-simulated-voyages-cso.html.
The COVID–19 Operations Manual for
Simulated and Restricted Voyages under
the Framework for Conditional Sailing
Order is found at https://www.cdc.gov/
quarantine/cruise/covid19-operations-
manual-cso.html.
Authority
The Technical Instructions and
Operations Manual are issued pursuant
to the Framework for Conditional
Sailing which was issued under the
authority of Sections 361 and 365 of the
Public Health Service Act (42 U.S.C.
264, 268) and 42 CFR 70.2, 71.31(b),
71.32(b).
Dated: May 5, 2021.
Sherri Berger,
Acting Chief of Staff, Centers for Disease
Control and Prevention.
[FR Doc. 2021–09895 Filed 5–6–21; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0049]
Advisory Committee on Immunization
Practices (ACIP)
AGENCY
: Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION
: Notice of meeting and request
for comment.
SUMMARY
: In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public. The meeting will be webcast live
via the World Wide Web.
DATES
: The meeting will be held on May
12, 2021, from 11:00 a.m. to 5:00 p.m.,
EDT (dates and times subject to change,
see the ACIP website for updates: http://
www.cdc.gov/vaccines/acip/
index.html). The public may submit
comments from May 10, 2021 through
May 12, 2021.
ADDRESSES
: For more information on
ACIP please visit the ACIP website:
http://www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified
by Docket No. CDC–2021–0049 by any
of the following methods:
•Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
•Mail: Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
MS–H24–8, Atlanta, GA 30329–4027,
Attn: May 12, 2021 ACIP Meeting.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT
:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION
: In
accordance with 41 CFR 102–3.150(b),
less than 15 calendar days’ notice is
being given for this meeting due to the
exceptional circumstances of the
COVID–19 pandemic and rapidly
evolving COVID–19 vaccine
development and regulatory processes.
The Secretary of Health and Human
Services has determined that COVID–19
is a Public Health Emergency. A notice
of this ACIP meeting has also been
posted on CDC’s ACIP website at: http://
www.cdc.gov/vaccines/acip/index.html.
In addition, CDC has sent notice of this
ACIP meeting by email to those who
subscribe to receive email updates about
ACIP.
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters to be Considered: The agenda
will include discussions on COVID–19
vaccines, including use of the Pfizer-
BioNTech COVID–19 vaccine under the
Food and Drug Administration’s (FDA)
expanded Emergency Use Authorization
(EUA) for adolescents 12–15 years of
age. A recommendation vote(s) is
scheduled. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: http://
www.cdc.gov/vaccines/acip/index.html.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
VerDate Sep<11>2014 19:05 May 07, 2021 Jkt 253001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\10MYN1.SGM 10MYN1
khammond on DSKJM1Z7X2PROD with NOTICES
